House Republicans Demand FDA Withdraw Race-Based Criteria For Monoclonal Antibodies

A group of over two dozen House Republicans sent a letter Thursday to Food and Drug Administration (FDA) Acting Commissioner Dr. Janet Woodcock, demanding the agency withdraw guidance related to the distribution of monoclonal antibodies in regards to race.

The Daily Caller first obtained the letter which was spearheaded by Republican North Carolina Rep. Dan Bishop and signed by 30 House Republicans. The lawmakers say the agency’s guidelines direct medical providers to consider race in addition to medical risk factors when prescribing monoclonal antibodies, saying the guidance violates the 14th Amendment.

Bishop’s office also mentioned the shortage of the treatments from the federal level and said the FDA’s race-based guidance has been implemented in states such as New York, Minnesota and Utah.

Minnesota’s Department of Health’s guidance states “FDA’s acknowledgment means that race and ethnicity alone, apart from other underlying health conditions, may be considered in determining eligibility.” Utah’s Department of Health put a point system in place that awards two points to patients of  “Non-White race or Hispanic/Latinx ethnicity,” while those suffering from congestive heart failure, hypertension and other medical problems are awarded one point for each such condition.
IV by Marcelo Leal is licensed under

Get latest news delivered daily!

We will send you breaking news right to your inbox

© 2013 - 2022 Constitutional Rights PAC, Privacy Policy